The male fertility market size has grown steadily in recent years. It will grow from $4.18 billion in 2025 to $4.36 billion in 2026 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to delayed parenthood trends, increasing prevalence of lifestyle-related infertility, growing incidence of varicocele and hormonal disorders, early adoption of IVF and ICSI procedures, rising awareness of male reproductive health.
The male fertility market size is expected to see steady growth in the next few years. It will grow to $5.12 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing male infertility diagnosis rates, growing acceptance of fertility testing among men, expansion of fertility services in emerging markets, rising investment in reproductive health research, growing use of preventive fertility supplements. Major trends in the forecast period include rising awareness of male infertility conditions, growing adoption of advanced semen analysis techniques, increasing demand for assisted reproductive technologies, higher consumption of male fertility supplements, expansion of specialized male fertility clinics.
The rising investment in fertility research is expected to drive the growth of the male fertility market in the coming years. Fertility research involves the scientific study of factors affecting reproductive health, including conception, pregnancy, and the enhancement of fertility outcomes. Funding for fertility research emphasizes studies on male fertility to gain a comprehensive understanding of reproductive health, improve overall fertility results, and address the crucial role male factors play in conception and reproductive success. For example, in October 2023, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, a US-based health department, awarded $2.26 million to investigate fertility-sparing treatments. As a result, the increasing investment in fertility research is fueling the growth of the male fertility market.
Major companies operating in the male fertility market are concentrating on developing innovative solutions, such as portable computer-assisted semen analysis (CASA) systems, to address the growing demand driven by delayed parenthood, increased awareness of male-factor infertility, and a shift toward decentralized, patient-friendly diagnostics. A portable computer-assisted semen analysis (CASA) system is a handheld or mobile device that utilizes software and imaging technology to automatically assess sperm quality, including count, motility, and morphology, enabling rapid, accurate, on-site fertility evaluation. For example, in November 2023, ExSeed Health, a UK-based, privately held medical-device and digital-health company, introduced the ExSeed CASA Lite, a compact computer-assisted semen analysis system designed for clinics and satellite laboratories. The ExSeed CASA Lite integrates a plug-and-play brightfield microscopy module with high-resolution video capture and cloud-enabled analysis software; it is classified as an IVD solution intended to measure key parameters (concentration, motility, and selected morphology metrics) with automated reporting. Its distinctive features include a large field-of-view high-resolution camera for whole-sample imaging, a web-based interface for fast results and clinic integration, and a small laboratory footprint that makes advanced semen analysis accessible beyond major ART centers.
In June 2024, Ferring Pharmaceuticals Inc., a Switzerland-based biopharmaceutical company, collaborated with Posterity Health Inc. to launch a male fertility program. Through this partnership, Ferring Pharmaceuticals Inc. seeks to enhance its reproductive-health patient engagement and digital services by informing and activating men about their fertility to encourage earlier, more equitable evaluation alongside female partners. Posterity Health Inc. is a US-based healthcare technology company specializing in virtual-first male reproductive health, providing a hybrid care model of telehealth and in-person services supported by its Male Management Platform and online male fertility assessment.
Major companies operating in the male fertility market are Bayer Healthcare Inc., Sanofi S.A., MERCK KGaA, Essity AB, Laboratory Corporation Of America Holdings, Endo International plc., Cook Medical, Zydus Lifesciences Ltd., Intas Pharmaceuticals Ltd., ASKA Pharmaceutical Co. Ltd, EMD Serono Inc., Dendreon Pharmaceuticals LLC, Vitrolife, CinnaGen Co., Aytu BioScience Inc., Kindbody, Cryos International, AdvaCare Pharma USA, Ferring Pharmaceuticals, Apricus Biosciences, Reprotech Ltd., Vios Fertility Institute, Andrology Solutions, DxNow, INVO Bioscience.
North America was the largest region in the male fertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the male fertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the male fertility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have moderately impacted the male fertility market by increasing the cost of imported diagnostic equipment, laboratory instruments, and specialized reagents used in fertility testing. These effects are most visible in advanced semen analysis and assisted reproductive technology segments, particularly in asia-pacific and latin america where imports are high. Higher tariffs can raise treatment and testing costs for end users. At the same time, tariffs are encouraging local manufacturing of diagnostic kits and supplements, supporting domestic production and cost optimization.
The male fertility market research report is one of a series of new reports that provides male fertility market statistics, including male fertility industry global market size, regional shares, competitors with a male fertility market share, detailed male fertility market segments, market trends and opportunities, and any further data you may need to thrive in the male fertility industry. This male fertility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Male fertility is generally defined as a man’s ability to impregnate his female partner. It is a complex process that relies on the production of healthy sperm, the proper functioning of the male reproductive organs, and the ability to achieve an erection and ejaculate so that sperm can reach the egg.
The main types of tests in male fertility include sperm agglutination, DNA fragmentation analysis, oxidative stress assessment, computer-assisted semen analysis, sperm penetration assays, and other test types. Sperm agglutination occurs when sperm cells clump together, usually due to the presence of antibodies either on the sperm cells themselves or in the surrounding seminal fluid. The primary treatment options include assisted reproductive technologies, varicocele surgery, and medications such as antioxidants, vitamins, minerals, amino acids, and enzymes. These treatments are used in hospitals, clinics, fertility centers, research institutes, and other end-user settings.
The male fertility market includes revenues earned by entities by diagnostic testing services, fertility consultations and counselling, fertility treatments and therapies or sperm banking and storage services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The male fertility market size is expected to see steady growth in the next few years. It will grow to $5.12 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing male infertility diagnosis rates, growing acceptance of fertility testing among men, expansion of fertility services in emerging markets, rising investment in reproductive health research, growing use of preventive fertility supplements. Major trends in the forecast period include rising awareness of male infertility conditions, growing adoption of advanced semen analysis techniques, increasing demand for assisted reproductive technologies, higher consumption of male fertility supplements, expansion of specialized male fertility clinics.
The rising investment in fertility research is expected to drive the growth of the male fertility market in the coming years. Fertility research involves the scientific study of factors affecting reproductive health, including conception, pregnancy, and the enhancement of fertility outcomes. Funding for fertility research emphasizes studies on male fertility to gain a comprehensive understanding of reproductive health, improve overall fertility results, and address the crucial role male factors play in conception and reproductive success. For example, in October 2023, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, a US-based health department, awarded $2.26 million to investigate fertility-sparing treatments. As a result, the increasing investment in fertility research is fueling the growth of the male fertility market.
Major companies operating in the male fertility market are concentrating on developing innovative solutions, such as portable computer-assisted semen analysis (CASA) systems, to address the growing demand driven by delayed parenthood, increased awareness of male-factor infertility, and a shift toward decentralized, patient-friendly diagnostics. A portable computer-assisted semen analysis (CASA) system is a handheld or mobile device that utilizes software and imaging technology to automatically assess sperm quality, including count, motility, and morphology, enabling rapid, accurate, on-site fertility evaluation. For example, in November 2023, ExSeed Health, a UK-based, privately held medical-device and digital-health company, introduced the ExSeed CASA Lite, a compact computer-assisted semen analysis system designed for clinics and satellite laboratories. The ExSeed CASA Lite integrates a plug-and-play brightfield microscopy module with high-resolution video capture and cloud-enabled analysis software; it is classified as an IVD solution intended to measure key parameters (concentration, motility, and selected morphology metrics) with automated reporting. Its distinctive features include a large field-of-view high-resolution camera for whole-sample imaging, a web-based interface for fast results and clinic integration, and a small laboratory footprint that makes advanced semen analysis accessible beyond major ART centers.
In June 2024, Ferring Pharmaceuticals Inc., a Switzerland-based biopharmaceutical company, collaborated with Posterity Health Inc. to launch a male fertility program. Through this partnership, Ferring Pharmaceuticals Inc. seeks to enhance its reproductive-health patient engagement and digital services by informing and activating men about their fertility to encourage earlier, more equitable evaluation alongside female partners. Posterity Health Inc. is a US-based healthcare technology company specializing in virtual-first male reproductive health, providing a hybrid care model of telehealth and in-person services supported by its Male Management Platform and online male fertility assessment.
Major companies operating in the male fertility market are Bayer Healthcare Inc., Sanofi S.A., MERCK KGaA, Essity AB, Laboratory Corporation Of America Holdings, Endo International plc., Cook Medical, Zydus Lifesciences Ltd., Intas Pharmaceuticals Ltd., ASKA Pharmaceutical Co. Ltd, EMD Serono Inc., Dendreon Pharmaceuticals LLC, Vitrolife, CinnaGen Co., Aytu BioScience Inc., Kindbody, Cryos International, AdvaCare Pharma USA, Ferring Pharmaceuticals, Apricus Biosciences, Reprotech Ltd., Vios Fertility Institute, Andrology Solutions, DxNow, INVO Bioscience.
North America was the largest region in the male fertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the male fertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the male fertility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have moderately impacted the male fertility market by increasing the cost of imported diagnostic equipment, laboratory instruments, and specialized reagents used in fertility testing. These effects are most visible in advanced semen analysis and assisted reproductive technology segments, particularly in asia-pacific and latin america where imports are high. Higher tariffs can raise treatment and testing costs for end users. At the same time, tariffs are encouraging local manufacturing of diagnostic kits and supplements, supporting domestic production and cost optimization.
The male fertility market research report is one of a series of new reports that provides male fertility market statistics, including male fertility industry global market size, regional shares, competitors with a male fertility market share, detailed male fertility market segments, market trends and opportunities, and any further data you may need to thrive in the male fertility industry. This male fertility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Male fertility is generally defined as a man’s ability to impregnate his female partner. It is a complex process that relies on the production of healthy sperm, the proper functioning of the male reproductive organs, and the ability to achieve an erection and ejaculate so that sperm can reach the egg.
The main types of tests in male fertility include sperm agglutination, DNA fragmentation analysis, oxidative stress assessment, computer-assisted semen analysis, sperm penetration assays, and other test types. Sperm agglutination occurs when sperm cells clump together, usually due to the presence of antibodies either on the sperm cells themselves or in the surrounding seminal fluid. The primary treatment options include assisted reproductive technologies, varicocele surgery, and medications such as antioxidants, vitamins, minerals, amino acids, and enzymes. These treatments are used in hospitals, clinics, fertility centers, research institutes, and other end-user settings.
The male fertility market includes revenues earned by entities by diagnostic testing services, fertility consultations and counselling, fertility treatments and therapies or sperm banking and storage services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Male Fertility Market Characteristics
3. Male Fertility Market Supply Chain Analysis
4. Global Male Fertility Market Trends and Strategies
5. Male Fertility Market Analysis of End Use Industries
7. Global Male Fertility Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Male Fertility Total Addressable Market (TAM) Analysis for the Market
9. Male Fertility Market Segmentation
10. Male Fertility Market Regional and Country Analysis
11. Asia-Pacific Male Fertility Market
12. China Male Fertility Market
13. India Male Fertility Market
14. Japan Male Fertility Market
15. Australia Male Fertility Market
16. Indonesia Male Fertility Market
17. South Korea Male Fertility Market
18. Taiwan Male Fertility Market
19. South East Asia Male Fertility Market
20. Western Europe Male Fertility Market
21. UK Male Fertility Market
22. Germany Male Fertility Market
23. France Male Fertility Market
24. Italy Male Fertility Market
25. Spain Male Fertility Market
26. Eastern Europe Male Fertility Market
27. Russia Male Fertility Market
28. North America Male Fertility Market
29. USA Male Fertility Market
30. Canada Male Fertility Market
31. South America Male Fertility Market
32. Brazil Male Fertility Market
33. Middle East Male Fertility Market
34. Africa Male Fertility Market
36. Male Fertility Market Competitive Landscape and Company Profiles
37. Male Fertility Market Other Major and Innovative Companies
40. Male Fertility Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Male Fertility Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses male fertility market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for male fertility? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The male fertility market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Test Type: Sperm Agglutination; DNA Fragmentation Technique; Oxidative Stress Analysis; Computer Assisted Semen Analysis; Sperm Penetration Assay; Other Test Types2) By Treatment Type: Assisted Reproductive Technology; Varicocele Surgery; Medication
3) By Supplement: Antioxidants; Vitamins; Minerals; Amino Acids; Enzymes
4) By End User: Hospitals And Clinics; Fertility Centers; Research Institutes; Other End Users
Subsegments:
1) By Sperm Agglutination: Seminal Plasma Agglutination Test; Sperm-Bound Antibody Tests2) By DNA Fragmentation Technique: Sperm DNA Fragmentation Index (DFI) Tests; Comet Assay
3) By Oxidative Stress Analysis: Reactive Oxygen Species (ROS) Measurement; Antioxidant Capacity Tests
4) By Computer Assisted Semen Analysis (CASA): Motility Analysis; Morphology Assessment
5) By Sperm Penetration Assay: Sperm-oocyte Interaction Tests; In Vitro Fertilization (IVF) Models
6) By Other Test Types: Hormonal Tests; Genetic Testing; Semen Culture Tests
Companies Mentioned: Bayer Healthcare Inc.; Sanofi S.A.; MERCK KGaA; Essity AB; Laboratory Corporation Of America Holdings; Endo International plc.; Cook Medical; Zydus Lifesciences Ltd.; Intas Pharmaceuticals Ltd.; ASKA Pharmaceutical Co. Ltd; EMD Serono Inc.; Dendreon Pharmaceuticals LLC; Vitrolife; CinnaGen Co.; Aytu BioScience Inc.; Kindbody; Cryos International; AdvaCare Pharma USA; Ferring Pharmaceuticals; Apricus Biosciences; Reprotech Ltd.; Vios Fertility Institute; Andrology Solutions; DxNow; INVO Bioscience
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Male Fertility market report include:- Bayer Healthcare Inc.
- Sanofi S.A.
- MERCK KGaA
- Essity AB
- Laboratory Corporation Of America Holdings
- Endo International plc.
- Cook Medical
- Zydus Lifesciences Ltd.
- Intas Pharmaceuticals Ltd.
- ASKA Pharmaceutical Co. Ltd
- EMD Serono Inc.
- Dendreon Pharmaceuticals LLC
- Vitrolife
- CinnaGen Co.
- Aytu BioScience Inc.
- Kindbody
- Cryos International
- AdvaCare Pharma USA
- Ferring Pharmaceuticals
- Apricus Biosciences
- Reprotech Ltd.
- Vios Fertility Institute
- Andrology Solutions
- DxNow
- INVO Bioscience
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.36 Billion |
| Forecasted Market Value ( USD | $ 5.12 Billion |
| Compound Annual Growth Rate | 4.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
